Brokerages Set Astera Labs, Inc. (NASDAQ:ALAB) Price Target at $244.75

Astera Labs, Inc. (NASDAQ:ALAB) has earned an average recommendation of “Moderate Buy” from the twenty-three research firms that are currently covering the firm, MarketBeat.com reports. Eleven investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $265.75.

ALAB has been the topic of a number of recent research reports. Bank of America upped their target price on shares of Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a research note on Tuesday, June 23rd. JPMorgan Chase & Co. increased their price target on shares of Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. Barclays increased their price target on shares of Astera Labs from $165.00 to $200.00 and gave the company an “equal weight” rating in a research note on Thursday, May 7th. Loop Capital started coverage on shares of Astera Labs in a research note on Thursday, March 5th. They issued a “buy” rating and a $250.00 price target on the stock. Finally, Royal Bank Of Canada increased their price target on shares of Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a research note on Wednesday, May 6th.

Astera Labs Stock Performance

ALAB stock opened at $483.02 on Wednesday. The company’s 50 day moving average price is $301.08 and its 200 day moving average price is $200.51. Astera Labs has a fifty-two week low of $85.85 and a fifty-two week high of $499.48. The firm has a market capitalization of $82.79 billion, a price-to-earnings ratio of 326.36, a PEG ratio of 5.23 and a beta of 3.95.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The firm had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. During the same period in the prior year, the firm earned $0.33 earnings per share. The business’s quarterly revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities analysts forecast that Astera Labs will post 1.84 EPS for the current fiscal year.

Insider Activity at Astera Labs

In other Astera Labs news, COO Sanjay Gajendra sold 400,000 shares of the stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $290.30, for a total value of $116,120,000.00. Following the transaction, the chief operating officer directly owned 5,064,213 shares in the company, valued at $1,470,141,033.90. This represents a 7.32% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 325,693 shares of the stock in a transaction that occurred on Friday, April 17th. The shares were sold at an average price of $172.14, for a total transaction of $56,064,793.02. Following the completion of the transaction, the chief executive officer owned 4,079,322 shares in the company, valued at $702,214,489.08. This represents a 7.39% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,968,942 shares of company stock worth $439,344,964 over the last quarter. 10.40% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Astera Labs

Hedge funds have recently modified their holdings of the business. Eurizon Capital SGR S.p.A. purchased a new stake in shares of Astera Labs during the 4th quarter worth $18,708,000. Nordea Investment Management AB purchased a new stake in shares of Astera Labs during the 4th quarter worth $2,028,000. Geneva Partners LLC purchased a new stake in shares of Astera Labs during the 3rd quarter worth $1,876,000. Swedbank AB boosted its position in shares of Astera Labs by 76.8% during the 4th quarter. Swedbank AB now owns 78,140 shares of the company’s stock worth $12,999,000 after purchasing an additional 33,940 shares in the last quarter. Finally, Numerai GP LLC boosted its position in shares of Astera Labs by 153.1% during the 3rd quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock worth $2,587,000 after purchasing an additional 7,992 shares in the last quarter. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.